Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows an updated study protocol revision: v3.5.4, replacing the previous revision v3.5.3. This reflects an updated version of the study-related documents linked to the trial.
    Difference
    0.1%
    Check dated 2026-05-18T03:48:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer revision tag was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:37:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T14:09:20.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added results-related data to the Study Record Dates, including Results First Posted 2025-10-29. Updated associated dates to reflect new published outcomes.
    Difference
    0.1%
    Check dated 2026-04-05T06:58:58.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0. The previous v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-21T20:25:28.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:56:04.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.